First observed in the SUSTAIN-6 trial, Rapid HbA1c reduction has been associated with worsening of pre-existing diabetic retinopathy [16]
Interrupting prolonged sitting with frequent short bouts of light-intensity activity in people with type 1 diabetes improves glycaemic control without increasing hypoglycaemia: the SIT-LESS randomised controlled trial
Written, informed consent to participate will be obtained from all participants
Storage: After first use Important Once the peptides are reconstituted (mixed with bacteriostatic water), they must be stored in the fridge to maintain stability
The DPP-4 inhibitors reduced HbA1c by 0.50.8% (58 mmol/mol) after 2426 weeks
Patients may only receive retatrutide through: Approved clinical trials registered with the MHRA and listed on the ISRCTN or ClinicalTrials.gov registries The MHRA Early Access to Medicines Scheme (EAMS) or compassionate use programmes, which allow access to promising unlicensed medicines for patients with serious conditions where no adequate alternative exists however, no such route is currently in place for retatrutide , and patients should not assume access is available outside of a formal trial It is strongly advised that patients do not attempt to source retatrutide through unregulated online pharmacies or grey-market suppliers
